Nov 28 (Reuters) - Arcturus Therapeutics Holdings Inc ARCT.O :
- JAPAN'S MINISTRY OF HEALTH, LABOUR AND WELFARE APPROVES CSL AND ARCTURUS THERAPEUTICS' ARCT-154
- ARCT-154 IS A SELF-AMPLIFYING MRNA (SA-MRNA) COVID-19 VACCINE FOR INITIAL VACCINATION AND BOOSTER FOR ADULTS 18 YEARS AND OLDER
(([email protected];))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$198.37 |
Change
0.030(0.02%) |
Mkt cap ! $96.23B | |||
| Open | High | Low | Value | Volume |
| $200.98 | $203.69 | $198.37 | $647.4M | 3.086M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 428 | $198.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $198.40 | 360 | 2 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| CSL (ASX) Chart |